Loading clinical trials...
Loading clinical trials...
Effect of Prebiotics in Saudi Adults With Type 2 Diabetes: Randomized Control Trail
Conditions
Interventions
oligofructose
Maltodextrin (Placebo)
Locations
1
Saudi Arabia
King Abdullah bin Abdulaziz University Hospital
Riyadh, Saudi Arabia
Start Date
September 13, 2026
Primary Completion Date
September 30, 2027
Completion Date
December 31, 2027
Last Updated
March 11, 2026
NCT07543666
NCT07550023
NCT07547774
NCT04888923
NCT07232537
NCT06815081
Lead Sponsor
Princess Nourah Bint Abdulrahman University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions